Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study

被引：0

作者：

Allouchery, M. ^{[1
]}

Tomowiak, C. ^{[2
]}

Singier, A. ^{[3
]}

Puyade, M. ^{[4
]}

Dari, L. ^{[5
]}

Pambrun, E. ^{[3
]}

Pariente, A. ^{[3
]}

Bezin, J. ^{[6
]}

Perault-Pochat, M. C. ^{[7
]}

Salvo, F. ^{[8
]}

机构：

[1] Univ Poitiers, Pharmacol Clin & Vigilances, CHU Poitiers, Poitiers, France

[2] CHU Poitiers, Onco Hematol & Therapie Cellulaire, Poitiers, France

[3] Univ Bordeaux, INSERM, BPH, U1219,Team Ahead, Bordeaux, France

[4] CHU Poitiers, Med Interne & Malad Infect, Poitiers, France

[5] CHU Bordeaux, Med Vasc, Bordeaux, France

[6] Univ Bordeaux, INSERM, BPH,Serv Pharmacol Med, U1219,Team Ahead,CHU Bordeaux,Pole Sante Publ, Bordeaux, France

[7] Univ Poitiers, Lab Neurosci Expt & Clin, Pharmacol Clin & Vigilances, CHU Poitiers,INSERM,UMR1084, Poitiers, France

[8] Univ Bordeaux, INSERM, BPH,Ctr Reg Pharmacovigilance,Serv Pharmacol Med, U1219,Team Ahead,CHU Bordeaux,Pole Sante Publ, Bordeaux, France

来源：

关键词：

anticoagulant; bleeding; drug-drug interaction; ibrutinib;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

CO-013

引用

页码：14 / 14

页数：1